Dexmedetomidine to Improve Outcomes During Emergence From Retroperitoneal Laparoscopic Surgery

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 10, 2014

Primary Completion Date

August 12, 2015

Study Completion Date

August 13, 2015

Conditions

Anesthesia

Interventions

DRUG

dexmedetomidine

an alpha-2 receptor agonist

OTHER

loading dose

0.8ug/kg of dexmedetomidine is given in 10 minutes

OTHER

sustaining dose

0.4ug/kg/min of dexmedetomidine is given

Trial Locations (1)

Xijing Hospital, Xi'an

All Listed Sponsors

lead

Air Force Military Medical University, China

OTHER

NCT02316236 - Dexmedetomidine to Improve Outcomes During Emergence From Retroperitoneal Laparoscopic Surgery | Biotech Hunter | Biotech Hunter